Status:
COMPLETED
18F-FDG PET Imaging Analysis of Antiepileptic Drug Response in BECTS
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions:
Benign Epilepsy With Centrotemporal Spikes
Eligibility:
All Genders
6-18 years
Brief Summary
This original article is a novel investigation on the metabolic characteristics of different patterns of antiepileptic drug (AED) responses in benign epilepsy with centrotemporal spikes (BECTS) patien...
Detailed Description
Purpose The current drug treatment of benign epilepsy with centrotemporal spikes (BECTS) mainly depends on the clinical experience of physicians. This study aimed to investigate different patterns of ...
Eligibility Criteria
Inclusion
- clinical diagnosis of BECTS; 2. aging between 6 and 18 years ; 3.taking MRI and EEG examination; 4. taking AEDs as prescribed; 5. continuous 12-month clinical follow-up after 18F-FDG PET examination; 6.the last seizure occurring earlier than 24 h before 18F-FDG PET study
Exclusion
- any history of neurological disorders, such as head trauma, tumor or infarct
Key Trial Info
Start Date :
June 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 20 2020
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT04357236
Start Date
June 1 2019
End Date
April 20 2020
Last Update
April 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Nuclear Medicine and PET/CT Center, The Second Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China, 310009